Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment

Christopher M. Jackson(Johns Hopkins University), Michael Lim(Stanford Medicine)

Clinical and Developmental Immunology

January 1, 2011

10.1155/2011/732413

Cited by 147

Related Papers

Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model

|PLoS ONE|2014|236

A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials

|Cancers|2019|104

CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future

|Frontiers in Immunology|2022|97

PD-L1 expression in medulloblastoma: an evaluation by subgroup

|Oncotarget|2018|62

Targeting Myeloid Cells in Combination Treatments for Glioma and Other Tumors

|Frontiers in Immunology|2019|52